SAME Stock Overview
Engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Risk Analysis
No risks detected for SAME from our risk checks.
PT Sarana Meditama Metropolitan Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp260.00 |
| 52 Week High | Rp370.00 |
| 52 Week Low | Rp186.00 |
| Beta | 0.80 |
| 11 Month Change | -9.72% |
| 3 Month Change | -12.75% |
| 1 Year Change | -14.47% |
| 33 Year Change | -35.96% |
| 5 Year Change | 4.84% |
| Change since IPO | 185.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| SAME | ID Healthcare | ID Market | |
|---|---|---|---|
| 7D | 2.4% | -2.2% | -0.1% |
| 1Y | -14.5% | 23.2% | 7.6% |
Return vs Industry: SAME underperformed the ID Healthcare industry which returned 23.2% over the past year.
Return vs Market: SAME underperformed the ID Market which returned 7.6% over the past year.
Price Volatility
| SAME volatility | |
|---|---|
| SAME Average Weekly Movement | 7.6% |
| Healthcare Industry Average Movement | 5.4% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.3% |
Stable Share Price: SAME has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: SAME's weekly volatility (8%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 2,761 | Jusup Halimi | www.emc.id |
PT Sarana Meditama Metropolitan Tbk engages in the hospital management of EMC Hospital Pulomas in Pulomas, East Jakarta. The company was founded in 1984 and is based in Jakarta, Indonesia. PT Sarana Meditama Metropolitan Tbk is a subsidiary of PT Elang Mahkota Teknologi Tbk.
PT Sarana Meditama Metropolitan Tbk Fundamentals Summary
| SAME fundamental statistics | |
|---|---|
| Market cap | Rp4.46t |
| Earnings (TTM) | -Rp1.15b |
| Revenue (TTM) | Rp1.69t |
2.6x
P/S Ratio-3,892x
P/E RatioIs SAME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SAME income statement (TTM) | |
|---|---|
| Revenue | Rp1.69t |
| Cost of Revenue | Rp1.13t |
| Gross Profit | Rp564.21b |
| Other Expenses | Rp565.35b |
| Earnings | -Rp1.15b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.067 |
| Gross Margin | 33.39% |
| Net Profit Margin | -0.068% |
| Debt/Equity Ratio | 23.5% |
How did SAME perform over the long term?
See historical performance and comparison